Methods and systems for de novo peptide sequencing using deep learning
US11573239B2 · Bioinformatics Solutions Inc. · priority 2017
| Patent | US11573239B2 ↗ |
| Status | Active |
| Priority date | 2017-07-17 |
| Filed | 2018-07-17 |
| Published (granted) | 2023-02-07 |
| Assignee | Bioinformatics Solutions Inc. |
| Claims | DeepNovo |
| Also published as | US20190018019A1, WO2020014767A1 |
Abstract
The present systems and methods introduce deep learning to de novo peptide sequencing from tandem mass spectrometry data. The systems and methods achieve improvements in sequencing accuracy over existing systems and methods and enables complete assembly of novel protein sequences without assisting databases. The present systems and methods are re-trainable to adapt to new sources of data and provides a complete end-to-end training and prediction solution, which is advantageous given the growing massive amount of data. The systems and methods combine deep learning and dynamic programming to solve optimization problems.
Why it is here
Claims DeepNovo: deep learning de novo sequencing of DDA spectra; the inventors are the DeepNovo paper’s authors.
Inventors (5)
Baozhen Shan, Ngoc Hieu Tran, Ming Li, Lei Xin, Xianglilan Zhang
An inventor links to an author page only where the same person is evident, never on a name alone.
Catalogued papers it cites (22)
- Sequence database searches via de novo peptide sequencing by tandem mass spectrometry (1997)
- De novo peptide sequencing via tandem mass spectrometry (1999)
- Implementation and Uses of Automated de Novo Peptide Sequencing by Tandem Mass Spectrometry (2001)
- A Dynamic Programming Approach to De Novo Peptide Sequencing via Tandem Mass Spectrometry (2001)
- PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometry (2003)
- De Novo Peptide Sequencing Based on a Divide-and-Conquer Algorithm and Peptide Tandem Spectrum Simulation (2004)
- PepNovo: de novo peptide sequencing via probabilistic network modeling (2005)
- InsPecT: Identification of Posttranslationally Modified Peptides from Tandem Mass Spectra (2005) added by the examiner
- NovoHMM: A Hidden Markov Model for de Novo Peptide Sequencing (2005)
- De Novo Peptide Identification via Tandem Mass Spectrometry and Integer Linear Optimization (2007)
- MSNovo: A Dynamic Programming Algorithm for de Novo Peptide Sequencing via Tandem Mass Spectrometry (2007)
- Proteome Analysis of Pitcher Fluid of the Carnivorous Plant Nepenthes alata (2008)
- Automated de novo protein sequencing of monoclonal antibodies (2008)
- De novo sequencing of peptides by MS/MS (2010)
- pNovo: De novo Peptide Sequencing and Identification Using HCD Spectra (2010)
- De Novo Sequencing and Homology Searching (2012)
- pNovo+: De Novo Peptide Sequencing Using Complementary HCD and ETD Tandem Mass Spectra (2013)
- Sequencing-Grade De novo Analysis of MS/MS Triplets (CID/HCD/ETD) From Overlapping Peptides (2013)
- UniNovo: a universal tool for de novo peptide sequencing (2013)
- Novor: Real-Time Peptide de Novo Sequencing Software (2015)
- Complete De Novo Assembly of Monoclonal Antibody Sequences (2016)
- De novo peptide sequencing by deep learning (2017) added by the examiner
Matched from the patent’s 64 literature citations by the rules the paper citation graph uses.
Cited by catalogued patents (2)
- US11644470B2 Systems and methods for de novo peptide sequencing using deep learning and spectrum pairs
- US12340874B1 Artificial neural network models for prediction of de novo sequencing of chains of amino acids
Cited by (41 patent families, 33 organisations)
- PrognomIQ company: GB2603051B, AU2022249074A1, WO2023039479A1, JP2024534992A
- Matterworks company: US12100484B2, US20230137741A1, WO2023077166A1
- BASF company: US20220139498A1, EP4352733A4
- Immatics company: JP2022543687A, WO2022184832A2
- Shandong University academic: CN110488020B, CN111599412B
- Amazon Technologies company: US10872601B1
- Beijing Information Science and Technology University academic: CN113033695B
- Bertis company: WO2021172946A1
- Bioinformatics Solutions company, its own earlier patent: US11644470B2
- Cornell University academic: US11215621B2
- ETH Zurich academic: EP3963590A1
- Fujifilm Business Innovation company: JP6922284B2
- Hong Kong Polytechnic University academic: WO2019196439A1
- Hunan University of Technology and Business academic: CN116825198B
- Institute of Computing Technology academic: CN110349621B
- Just-Evotec Biologics company: US11587645B2
- Lesaffre et Compagnie company: FR3159254A1
- Life Technologies company: US11664090B2
- Nanjing Drum Tower Hospital hospital: CN110111848B
- North China University of Technology academic: CN113960152B
- OPPO Guangdong Mobile Telecommunications company: CN110991619A
- Qingdao University of Science and Technology academic: CN111081311A
- Quantum-Si company: EP3966824A1
- Ro5 company: US12511869B2
- Shanghai Yisuan Biotechnology company: CN113851188A
- Shenzhen Chengqi Biotechnology company: CN115206422B
- Shenzhen Intellifusion Technologies company: CN110413539B
- Shenzhen Sailu Medical Technology company: CN116596933B
- South China Normal University academic: CN114781575B
- Translational Genomics Research Institute academic: US11587644B2
- University of Toronto academic: US12655176B2
- Ventana Medical Systems company: WO2021191421A1
- Verily Life Sciences company: US12340874B1
Every family, of any applicant, that cites this one, as Google Patents lists them; an assignee is given its English name.